BioPharma Credit PLC (LON:BPCR)
London
· Delayed Price · Currency is GBP · Price in USD 0.930
-0.010 (-1.06%)
At close: Mar 6, 2026
BioPharma Credit Revenue
BioPharma Credit had revenue of $83.78M USD in the half year ending June 30, 2025, with 6.70% growth. This brings the company's revenue in the last twelve months to $154.66M, up 13.42% year-over-year. In the year 2024, BioPharma Credit had annual revenue of $150.03M with 10.53% growth.
Revenue (ttm)
$154.66M
Revenue Growth
+13.42%
P/S Ratio
6.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
784.29M GBP
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Molten Ventures | 137.10M |
| Oakley Capital Investments | 74.01M |
| Jupiter Fund Management | 431.00M |
| IntegraFin Holdings | 156.80M |
| Polar Capital Holdings | 228.77M |
| Pollen Street Group | 127.94M |
| Foresight Environmental Infrastructure | 15.39M |
| Foresight Group Holdings | 162.32M |